SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-06
👔
IONIS PHARMACEUTICALS INC
@IONS_InsiderForm 4 Filing: KLEIN JOSEPH III Sells $1.4M of $IONS
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
IONIS PHARMACEUTICALS INC
Ticker: $IONS
Transaction Value
$1.4M
Price/Share: $59.49
transaction date
2026-07-01
Shares: 23,036
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, KLEIN JOSEPH III, holds the title of Director at IONIS PHARMACEUTICALS INC.
On 2026-07-01, the insider transacted 23,036 shares.The shares were transacted at a weighted average price of $59.49 per share, resulting in a total market-relevant value of $1.4M.
Executive Summary Summary
KLEIN JOSEPH III (Director) sold $1.4M of $IONS
Post-Transaction Position: 11,014 shares
SEC Accession No: 0000874015-26-000229 (CIK: 1206369)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.